Physicians must change their approaches to finding culprit drugs when treating Stevens-Johnson syndrome/toxic epidermal necrolysis, according to a study.Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a severe mucocutaneous desquamative disease that is almost always triggered by certain medications, Dayan J. Li, MD, PhD, of the department of dermatology at the Brigham and
In the absence of a lab test, identifying culprit drugs in patients with SJS/TEN is difficult, and patients take on average six medications at the time of their reaction, the authors of a new study write.